echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Huadong Medicine Acarbose Tablets Obtained U.S. FDA Approval Number

    Huadong Medicine Acarbose Tablets Obtained U.S. FDA Approval Number

    • Last Update: 2020-09-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Introduction: Akapo sugar tablets are currently an important variety in the field of diabetes in East China.
    . Today, East China Pharmaceuticals announced that its wholly-owned subsidiary, Hangzhou Sino-American East China Pharmaceutical Co., Ltd., has approved a brief application for a new drug (ANDA, or U.S. generic drug application) for oral solid preparations of Acapo sugar tablets filed with the FDA.
    Acapo sugar is an alpha-glycosidease inhibitor originally developed by Bayer Pharmaceuticals of Germany, listed in Germany in 1990, approved for listing in China in 1994 and approved and listed by the FDA in 1995.
    Akapo sugar, as an oral hypoglycemic drug, can competitively inhibit glucosine hydrolysase in the intestines, inhibit starch decomposition into glucose, thereby reducing the absorption of glucose in the intestines, thereby alleviating post-meal hyperglycemia, to reduce the role of blood sugar.
    is currently an important variety in the field of diabetes in East China, with global sales of Acapo sugar preparation products of $689 million in 2019.
    Akapo sugar tablets produced in East China, China and the United States were the first in China to be approved for listing in the Austrian market in the European Union in December 2019 through the evaluation of the quality and efficacy of generic drugs.
    This application for Acapo sugar tablets was submitted in October 2019 and approved by the FDA in August 2020, making it the first FDA approved by the U.S. FDA for domestic Acapo sugar preparation products and the first Acapo sugar preparation product to be licensed in both China, the U.S. and the European Union in Austria.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.